Lee Yangkyu, Park Hyunjin, Lee Hyejung, Cho Jai Young, Yoon Yoo-Seok, Choi Young-Rok, Han Ho-Seong, Jang Eun Sun, Kim Jin-Wook, Jeong Sook-Hyang, Ahn Soomin, Kim Haeryoung
Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
J Pathol Transl Med. 2018 Mar;52(2):85-92. doi: 10.4132/jptm.2017.11.13. Epub 2017 Nov 24.
We aimed to determine the clinicopathological significance of the gross classification of hepatocellular carcinoma (HCC) according to the Korean Liver Cancer Association (KLCA) guidelines.
A retrospective analysis was performed on 242 cases of consecutively resected solitary primary HCC between 2003 and 2012 at Seoul National University Bundang Hospital. The gross classification (vaguely nodular [VN], expanding nodular [EN], multinodular confluent [MC], nodular with perinodular extension [NP], and infiltrative [INF]) was reviewed for all cases, and were correlated with various clinicopathological features and the expression status of "stemness"-related (cytokeratin 19 [CK19], epithelial cell adhesion molecule [EpCAM]), and epithelial-mesenchymal transition (EMT)-related (urokinase plasminogen activator receptor [uPAR] and Ezrin) markers.
Significant differences were seen in overall survival (p=.015) and disease-free survival (p = .034) according to the gross classification; INF type showed the worst prognosis while VN and EN types were more favorable. When the gross types were simplified into two groups, type 2 HCCs (MC/NP/INF) were more frequently larger and poorly differentiated, and showed more frequent microvascular and portal venous invasion, intratumoral fibrous stroma and higher pT stages compared to type 1 HCCs (EN/VN) (p<.05, all). CK19, EpCAM, uPAR, and ezrin expression was more frequently seen in type 2 HCCs (p<.05, all). Gross classification was an independent predictor of both overall and disease-free survival by multivariate analysis (overall survival: p=.030; hazard ratio, 4.118; 95% confidence interval, 1.142 to 14.844; disease-free survival: p=.016; hazard ratio, 1.617; 95% confidence interval, 1.092 to 2.394).
The gross classification of HCC had significant prognostic value and type 2 HCCs were associated with clinicopathological features of aggressive behavior, increased expression of "stemness"- and EMT-related markers, and decreased survival.
我们旨在根据韩国肝癌协会(KLCA)指南确定肝细胞癌(HCC)大体分类的临床病理意义。
对2003年至2012年期间在首尔国立大学盆唐医院连续切除的242例孤立性原发性肝癌病例进行回顾性分析。对所有病例的大体分类(模糊结节型[VN]、膨胀结节型[EN]、多结节融合型[MC]、结节伴结节周围扩展型[NP]和浸润型[INF])进行了评估,并将其与各种临床病理特征以及“干性”相关(细胞角蛋白19[CK19]、上皮细胞粘附分子[EpCAM])和上皮-间质转化(EMT)相关(尿激酶型纤溶酶原激活物受体[uPAR]和埃兹蛋白)标志物的表达状态进行关联。
根据大体分类,总生存期(p = 0.015)和无病生存期(p = 0.034)存在显著差异;浸润型预后最差,而模糊结节型和膨胀结节型预后较好。当将大体类型简化为两组时,与1型肝癌(EN/VN)相比,2型肝癌(MC/NP/INF)更常体积较大且分化差,微血管和门静脉侵犯、瘤内纤维间质更常见,且pT分期更高(均p < 0.05)。2型肝癌中CK19、EpCAM、uPAR和埃兹蛋白表达更常见(均p < 0.05)。通过多变量分析,大体分类是总生存期和无病生存期的独立预测因素(总生存期:p = 0.030;风险比,4.118;95%置信区间,1.142至14.844;无病生存期:p = 0.016;风险比,1.617;95%置信区间,1.092至2.394)。
肝癌的大体分类具有显著的预后价值,2型肝癌与侵袭性行为的临床病理特征、“干性”和EMT相关标志物表达增加以及生存期缩短相关。